AMRC CFO executes option exercises and sells 15,600 shares
Rhea-AI Filing Summary
Ameresco, Inc. (AMRC) reporting person Mark Chiplock, EVP, CFO & CAO, executed a series of transactions under a Rule 10b5-1 trading plan adopted on 06/05/2025. On 10/06/2025, 10/07/2025, and 10/08/2025 he exercised portions of stock options with a $13.37 exercise price and sold the resulting shares in multiple market transactions. The filings show 15,600 shares sold in total (5,900 + 5,900 + 3,800) at weighted average sale prices of about $39.51 and $39.75 across the trade dates, while the options exercised were originally granted with an exercise price of $13.37.
Following these transactions the reporting person’s beneficial ownership in Class A common stock is reported at 1,189 shares held directly; derivative holdings indicate remaining option-related rights equal to 19,798 underlying shares after the reported exercises and sales. The Form 4 includes footnotes disclosing sale price ranges and the 10b5-1 plan used for the sales.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating preplanned transactions intended to provide an affirmative defense
- Exercise price was $13.37, materially lower than the reported weighted sale prices near $39.5, demonstrating option exercise then sale execution
Negative
- Total disposition of 15,600 Class A shares reduces the reporting person’s direct holdings to 1,189 shares
- Significant open-market sales in a short window (three days) could be viewed as a supply event for market liquidity analysis
Insights
Insider followed a pre-established 10b5-1 plan to sell option-funded shares.
The reporting person adopted a Rule 10b5-1 trading plan on 06/05/2025 and executed scheduled option exercises and market sales on 10/06/2025 through 10/08/2025. The pattern shows option exercises at an exercise price of $13.37 followed by contemporaneous open-market sales at weighted average prices near $39.5.
This structure is typical for executives monetizing vested equity while using an affirmative defense to avoid timing claims. Items to watch include any future Form 4s that modify or terminate the 10b5-1 plan and updates to remaining option balances or direct holdings within the next reporting period.
Material share disposition of 15,600 shares occurred via multiple transactions.
The reported sales total 15,600 Class A shares sold in tranches tied to option exercises, with weighted average sale prices reported in ranges between $39.45–$39.82 across the dates. The filings explicitly provide the number of shares sold and the price ranges for the trades.
For market impact, investors may note the timing and size relative to average daily volume (not disclosed here). Monitor upcoming filings for additional insider sales or changes in direct beneficial ownership reported as 1,189 Class A shares and derivative holdings equating to 19,798 underlying shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to puchase) | 3,800 | $0.00 | -- |
| Exercise | Class A Common Stock | 3,800 | $13.37 | $51K |
| Sale | Class A Common Stock | 3,800 | $39.75 | $151K |
| Exercise | Stock Option (right to puchase) | 5,900 | $0.00 | -- |
| Exercise | Class A Common Stock | 5,900 | $13.37 | $79K |
| Sale | Class A Common Stock | 5,900 | $39.51 | $233K |
| Exercise | Stock Option (right to puchase) | 5,900 | $0.00 | -- |
| Exercise | Class A Common Stock | 5,900 | $13.37 | $79K |
| Sale | Class A Common Stock | 5,900 | $38.92 | $230K |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.45 to $39.59, inclusive. The reporting person undertakes to provide to Ameresco, Inc., any security holder of Ameresco, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.72 to $39.82, inclusive. On August 6, 2019, the reporting person was granted an option to purchase 40,000 shares of Class A common stock. The option vested based on continued service to Ameresco, Inc. and performance relative to goals established for the three-year performance period from January 1, 2019 to December 31, 2021. Based on the level of achievement of these goals, as determined by Ameresco, Inc.'s Board of Directors, this option vested as to 36,000 shares.
